UNSPSC 51284402: Ceftobiprole

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5T97333YZK. European Medicines Agency schedules Ceftobiprole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25723. Ceftobiprole generally arises in the molecular formula C20H22N8O6S2. The term CEFTOBIPROLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 3, 2005, list 54.) Most nations schedule ceftobiprole under HS 29419000 and SITC 54139.

As of Q4 2014, CEFTOBIPROLE remains the US FDA Preferred Term for this commodity. Ceftobiprole bears US NLM identifiers UMLS ID C1100584 and NCI Concept Code C65306. SMILES: S1C2N(C(=O)C2NC(=O)C(=C2\[NH]SC(N2)N)\N=O)C(=C(C1)/C=C1\CCN(C2CCNC2)C1=O)C(=O)O.

UNSPSC 51284402 Ceftobiprole, a Commodity code, nominally addresses a specific antibiotic pharmaceutical, but recent state and local solicitations tagged under this code actually cover a much broader range of pharmaceutical procurement, emergency medical supplies, and drug-management products including naloxone, over-the-counter medications, generic pharmaceuticals, and first-aid supplies for emergency response and public health programs. State and local governments are buying these products through a mix of issuing bodies: county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire and rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (MMCAP, Minnesota). The scope spans acute-care medical supplies for emergency responders, community health initiatives, pharmacy benefit programs, and bulk pharmaceutical distribution through authorized wholesalers.

Recent activity is concentrated in Florida, Texas, and the upper Midwest, with MMCAP's Minnesota-based cooperative purchasing reaching into Oregon and other participating jurisdictions. Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually, response due July 26, 2023); the City of Tampa's IFB for medical and first-aid supplies to the Fire Department Rescue Division (169 line items, estimated contract value $700,000, designated as a sheltered market set-aside for certified Small Local Business Enterprises with a 5 percent bid discount, response due March 13, 2026); MMCAP's RFP for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities (response due March 26, 2026, contract effective July 1, 2026); and the Texas HHS Commission's RFI for direct-to-manufacturer prescription programs (response due April 3, 2026). The mismatch between the code's nominal scope (a single antibiotic) and the actual procurement activity suggests the code may be misapplied in tagging systems, though the recent opportunities show active state and local purchasing of pharmaceutical and medical-supply products at scale.